Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “lung cancer”
Sponsor: M.D. Anderson Cancer Center
Lung Cancer
United States
Sponsor: AstraZeneca
Non-small Cell Lung Cancer
Spain
Sponsor: National Cancer Institute (NCI)
Lung Non-Small Cell Carcinoma · Stage II Lung Cancer AJCC v8 · Stage IIIA Lung Cancer AJCC v8 · Stage IIIB Lung Cancer AJCC v8
United States
- Stereotactic Ablative Radiotherapy for Oligo-Progressive Non Small Cell Lung CancerActive Not Recruiting
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Lung Cancer Metastatic
Canada
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Colorectal Neoplasms · Carcinoma, Non-Small-Cell Lung · Stomach Neoplasms · Pancreatic Ductal Adenocarcinoma
United States, Canada, China, France, Israel +5 more
- A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid TumorsRecruiting
Sponsor: Pfizer
Advanced/Metastatic Solid Tumors · Bladder Cancer · Urothelial Carcinoma · Advanced Non-Small Cell Lung Cancer
United States, Canada, Puerto Rico, Spain, United Kingdom
- Data Collection of Standard Care and Evaluation of NHLBI Patients and DonorsEnrolling By Invitation
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Wide Spectrum of Diseases · Hematologic Diseases
United States
- A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC)Active Not Recruiting
Sponsor: Amgen
Relapsed/Refractory Small Cell Lung Cancer
United States, Austria, Belgium, Denmark, France +13 more
Sponsor: Tang-Du Hospital
Non-small Cell Lung Cancer
China
- A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)Recruiting
Sponsor: Merck Sharp & Dohme LLC
Lung Neoplasm Malignant
United States, Brazil, Chile, China, Germany +6 more
- Allogeneic NK Cell Therapy Combined With Standard Maintenance Treatment in Advanced Solid TumorsNot Yet Recruiting
Sponsor: BOE Technology Group Co., Ltd.
NSCLC (Advanced Non-small Cell Lung Cancer) · Colorectal Cancer · Advanced Solid Tumors
Sponsor: Pfizer
Small Cell Lung Cancer (SCLC)
United States, Australia, China, France, Germany +5 more
- A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2Active Not Recruiting
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Carcinoma, Non-Small-Cell Lung · Ovarian Neoplasms · Endometrial Neoplasms · Head and Neck Neoplasms
United States, Australia, Canada, Italy, South Korea +2 more
Sponsor: BioNTech SE
Advanced Solid Tumor
United States, Australia, Belgium, Germany, Italy +3 more
- DESTINY-PANTUMOUR04Recruiting
Sponsor: AstraZeneca
Adenocarcinoma (NOS) · Anal Cancer · Bladder Cancer · Cervical Cancer
United States
Sponsor: University of Utah
Non-Small Cell Lung Cancer Metastatic
United States
Sponsor: Regeneron Pharmaceuticals
Cancer-Associated Thrombosis (CAT)
United States, Georgia, Japan
Sponsor: Boehringer Ingelheim
Lung Cancer, Non-squamous, Non-small Cell
Australia, China, France, Germany, Japan +2 more
Sponsor: Abramson Cancer Center at Penn Medicine
Lung Cancer · Adherence, Patient
United States
- DAREON™-9: A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With Small Cell Lung Cancer When Taken Together With a Single Agent ChemotherapyActive Not Recruiting
Sponsor: Boehringer Ingelheim
Small Cell Lung Carcinoma (SCLC)
United States, France, Germany, Poland, United Kingdom
- Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid TumorsActive Not Recruiting
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Colorectal Neoplasms · Carcinoma, Non-Small-Cell Lung · Exocrine Pancreatic Cancer · Carcinoma, Squamous Cell of Head and Neck
United States, Canada, France, Germany, Italy +2 more
Sponsor: Mirati Therapeutics Inc.
Carcinoma, Non-Small-Cell Lung
United States, Argentina, Australia, Austria, Belgium +30 more
- Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen MesothelinActive Not Recruiting
Sponsor: Memorial Sloan Kettering Cancer Center
Malignant Pleural Disease · Mesothelioma · Metastases · Lung Cancer
United States
- A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.Active Not Recruiting
Sponsor: Pfizer
Carcinoma, Pancreatic Ductal · Colorectal Neoplasms · Carcinoma, Non-Small-Cell Lung
United States, Puerto Rico
Sponsor: Jiangmen Central Hospital
Lung · Radiotherapy